Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Haleon Plc on August 1, 2025, for the month of August 2025. Haleon is a global leader in consumer health with a portfolio spanning Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health. The filing specifically addresses the company's total voting rights and capital structure as of July 31, 2025.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on capital structure and share counts rather than financial performance metrics.
Material Changes
The filing discloses the following capital structure data as of July 31, 2025:
- Total ordinary shares issued: 8,987,651,560 (par value £0.01 each).
- Treasury shares held: 3,880,205.
- Ordinary shares with voting rights: 8,983,771,355.
No material changes to financial performance or operational status are reported in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves as a regulatory notification regarding the denominator for calculating notifiable interests under the FCA's Disclosure Guidance and Transparency Rules.
Key Facts for Investor Verification
- Verify the total number of voting shares (8,983,771,355) for compliance with disclosure thresholds.
- Confirm the number of treasury shares (3,880,205) held by the company.
- Note that this filing does not contain financial results; investors should refer to Form 20-F or quarterly reports for performance data.